In this free webinar, gain insight into the principles of mRNA and LNP technology and their unique advantages for in vivo CAR ...

Vaximm, which specializes in oral T-cell immunotherapies for cancer, is naming Sébastien Wieckowski, PhD, Chief Scientific ...

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies for cancer, today announced the ...

Context Therapeutics Inc. ('Context” or the 'Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T ...

The 44th J.P.Morgan Healthcare Conference (JPMHC) was successfully held in San Francisco, the United States, from January 12 to 15. As one of the most influential annual events in the global ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...

Company Announcement Based on the topline results from the EPCORE® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss ...

The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...

The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...

President Dr. Valerie Fuller attended a White House event today focused on the Rural Health Transformation Program (RHTP) and ...

A clinical-stage biotechnology company with operations in Guangzhou, China and Cambridge, Massachusetts. The company runs ...

Louisiana will receive over $208 million through the Rural Health Transformation Program, established under President Donald ...